ENDRA Life Sciences Inc. — Director's Dealing 2021

Jan 14, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ENDRA Life Sciences Inc. (NDRA)
CIK: 0001681682
Period of Report: 2021-01-12

Reporting Person: Maloberti Renaud Bertrand (Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-12	Common Stock	S	6304	$1.05	Disposed	15276	Direct
2021-01-13	Common Stock	S	13696	$1.10	Disposed	1580	Direct

Footnotes

F1: Represents shares sold pursuant to a Rule 10b5-1 trading plan.